まとめ
米国国立衛生研究所 (NIH) の未診断疾患プログラム (Undiagnosed Diseases Program) は,全エクソーム配列解析を用いて,39の希少疾患の診断に成功しました. このイニシアチブは,パーソナルゲノミクスと,複雑なゲノム情報のためのデータ管理技術を推進しています.
科学分野:
- ゲノム医学はゲノム医学である.
- 希少疾患の診断 希少疾患の診断
- クリニカルゲノミクス 臨床ゲノミクス
背景:
- 米国国立衛生研究所 (NIH) の未診断疾患プログラム (UDP) は,希少疾患における診断上の課題に取り組むために設立されました.
- ゲノムテクノロジーは,従来の方法では捉えられない状態を診断するための強力なツールを提供します.
研究 の 目的:
- 臨床環境における大規模なエクソームシーケンシングの実施の効果と成功を評価する.
- 診断されていないまれな疾患の患者に対するゲノミクスによる診断の効果を実証する.
- 大量のゲノムデータの管理と解釈における進歩を強調する.
主な方法:
- 全エクソームシーケンシングは,未診断疾患の患者集団で実施されました.
- ゲノムデータ分析パイプラインが開発され,変種識別と解釈のために適用されました.
- 診断を確立するために,特定された遺伝子変異の臨床的相関が実施されました.
主要な成果:
- 128のエクソームの配列解析により,39の希少疾患の診断が示されました.
- このプログラムは,診断の成功率を大幅に高め,患者の治療結果を向上させました.
- ゲノムデータの"津波"を管理するための新しい方法が開拓されました.
結論:
- 大規模な臨床ゲノミクス,特に全エクソームシーケンシングは,まれな疾患の診断に有効です.
- NIH UDPの成功は,ゲノミクスを日常的な臨床実践に統合するためのモデルを提供します.
- ゲノムデータの分析と管理における継続的なイノベーションは,パーソナルゲノミクスの将来にとって極めて重要です.
関連する概念動画
RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...


